HHS declared a public health emergency in Puerto Rico due to Hurricane Fiona; nearly 1 in 10 Americans suffered from depression in 2020, and a task force recommended doctors screen all adults aged younger than 65 for anxiety; advances in cancer research have led to reduced cancer death rates.
HHS Secretary Xavier Becerra declared yesterday a public health emergency for Puerto Rico due to the flooding impact of Hurricane Fiona. This declaration grants CMS beneficiaries, providers, and suppliers more flexibility to meet emergency health needs. HHS has sent a 15-person health and medical task force and a 10-person incident management team, both of which are working with health authorities and emergency response officials in Puerto Rico. According to the HHS news release, additional staff from the National Disaster Medical System, the US Public Health Service Commissioned Corps, and the CDC are ready to provide medical care and public health support in Puerto Rico.
Nearly 1 in 10 Americans 12 years and older experienced a major depressive episode in 2020, The Hill reported. According to a study published in the American Journal of Preventive Medicine, more than 9% of Americans in a nationally representative sample of 278,176 individuals suffered from depression in 2020, and rates of depression were higher among Americans younger than 25. More than 17% of young adults and 16.9% of adolescents experienced a major depressive episode in 2020, increasing from 10.3% and 12.7%, respectively, in 2015. While the COVID-19 pandemic played a role in these increases, the researchers said depression rates were worsening long before the pandemic. In other mental health news, the US Preventive Services Task Force (USPSTF) announced Tuesday its recommendation that doctors screen all adults younger than 65 years for anxiety. The USPSTF made a similar recommendation for Americans under 18 earlier this year, and said this new guidance aims to help prevent mental health disorders from going undetected and untreated for years. The task force will finalize the guidance after reviewing public comments.
Advances in cancer research, treatments, and screening have led to a drop in cancer death rates, according to a report published today by the American Association for Cancer Research. The 2022 Cancer Progress Report announced that, as of January 2022, there are more than 18 million cancer survivors in the United States—up from 3 million survivors in 1971. The report also noted an accelerated decline in cancer mortality rates, with a 2.3% decrease in cancer deaths every year between 2016 and 2019. This is likely a result of 8 new anticancer therapeutics being granted FDA approval and 10 anticancer therapeutics and 2 new diagnostic imaging agents being granted FDA expanded use.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Research Shows Prior Authorization Denials Delay Critical Immunology Care
May 10th 2024Results featured at the Academy of Managed Care Pharmacy 2024 annual meeting revealed a pattern of prior authorization rejections that could delay necessary therapeutic treatments for various patient groups.
Read More